Scott Koenig - Jan 27, 2023 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Stock symbol
GLYC
Transactions as of
Jan 27, 2023
Transactions value $
$26,775
Form type
4
Date filed
1/30/2023, 03:13 PM
Previous filing
Dec 1, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Options Exercise $26.8K +10.5K +200% $2.55 15.8K Jan 27, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLYC Stock Option (right to buy) Options Exercise $0 -10.5K -100% $0.00* 0 Jan 27, 2023 Common Stock 10.5K $2.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vested on May 18, 2022 and are fully exercisable.